Dyax Corp. (DYAX) Announces Fourth Quarter and Full Year 2013 Financial Results
2/28/2014 7:29:53 AM
Dyax Corp. (NASDAQ: DYAX) today announced financial results for the fourth quarter and year ended December 31, 2013. Dyax will host a webcast and conference call at 8:30 a.m. (ET) today to review financial results and provide updates regarding its key value drivers – the hereditary angioedema (HAE) business, including KALBITOR® (ecallantide) and DX-2930, and the Licensing and Funded Research Portfolio (LFRP).
Help employers find you! Check out all the jobs and post your resume.
comments powered by